Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 170.79
+1.23 (0.73%)
Apr 22, 2026, 3:30 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 26.58 billion as of April 22, 2026. Its market cap has decreased by -24.39% in one year.
Market Cap
26.58B
Enterprise Value
45.86B
Revenue
27.97B
Ranking
n/a
PE Ratio
22.36
Stock Price
170.79
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 26.58B, a decrease of -53.21%. That is a compound annual growth rate of -8.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 26.58B | -31.52% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 579.54B |
| Anthem Biosciences | 404.98B |
| OneSource Specialty Pharma | 176.95B |
| Concord Biotech | 113.16B |
| Blue Jet Healthcare | 73.32B |
| Supriya Lifescience | 51.39B |
| Zota Health Care | 44.54B |
| Panacea Biotec | 21.97B |